Bumol Thomas F. 4
4 · OMEROS CORP · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Omeros (OMER) Director Thomas F. Bumol Receives Option Award
What Happened
Thomas F. Bumol, a non-employee director of Omeros Corporation (OMER), was granted an option award for 15,000 shares on June 18, 2026. The Form 4 reports the derivative grant (15,000 shares) with a reported price of $0.00, meaning no cash was exchanged at grant — this is a stock option award, not an immediate purchase of common shares.
Key Details
- Transaction date: 2026-06-18; Form 4 filed: 2026-06-22 (filing within the normal reporting window).
- Award: option to purchase 15,000 shares (reported as a derivative grant); reported price $0.00.
- Shares owned after transaction: not specified in this filing.
- Footnote summary: the grant is an automatic annual option under Omeros’ non-employee director compensation policy (F1). The option will fully vest and become exercisable the day before the 2027 annual meeting, provided Bumol continues as a director through that date (F2).
- No exercise or sale occurred — this is a grant of an unexercised option.
Context: This is a routine, annual non-employee director compensation award rather than a market purchase or sale. Such grants are common and typically intended to align directors’ interests with shareholders; because the option vests in the future, it does not represent immediate buying or selling of stock.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1][F2]2026-06-18+15,000→ 15,000 totalExercise: $10.28Exp: 2036-06-17→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
- [F2]This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.